These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1719444)
21. Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions. Altier N; Stewart J Behav Brain Res; 1997 Dec; 89(1-2):151-65. PubMed ID: 9475623 [TBL] [Abstract][Full Text] [Related]
23. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies. Juszczak M; Boczek-Leszczyk E; Stempniak B J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491 [TBL] [Abstract][Full Text] [Related]
25. Selective neurokinin NK1 and NK2 receptor agonists infused in the substantia nigra of the rat increase vacuous chewing. Liminga U Eur J Pharmacol; 1993 Apr; 235(2-3):177-81. PubMed ID: 7685289 [TBL] [Abstract][Full Text] [Related]
26. Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK(2) receptors. Kerr KP; Thai B; Coupar IM Br J Pharmacol; 2000 Dec; 131(7):1461-7. PubMed ID: 11090121 [TBL] [Abstract][Full Text] [Related]
27. Coexistence of three tachykinin receptors coupled to Ca++ signaling pathways in intestinal muscle cells. Hellstrom PM; Murthy KS; Grider JR; Makhlouf GM J Pharmacol Exp Ther; 1994 Jul; 270(1):236-43. PubMed ID: 8035320 [TBL] [Abstract][Full Text] [Related]
28. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence. Olds ME Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732 [TBL] [Abstract][Full Text] [Related]
29. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists. Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583 [TBL] [Abstract][Full Text] [Related]
30. Tachykinin NK(3)receptor involvement in anxiety. Ribeiro SJ; Teixeira RM; Calixto JB; De Lima TC Neuropeptides; 1999 Apr; 33(2):181-8. PubMed ID: 10657489 [TBL] [Abstract][Full Text] [Related]
31. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation. Deschamps K; Couture R Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109 [TBL] [Abstract][Full Text] [Related]
32. Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviours in mice. Ravard S; Betschart J; Fardin V; Flamand O; Blanchard JC Brain Res; 1994 Jul; 651(1-2):199-208. PubMed ID: 7522932 [TBL] [Abstract][Full Text] [Related]
34. Neurokinin-alpha injected into the ventral tegmental area elicits a dopamine-dependent behavioral activation in the rat. Burns LH; Kelley AE Pharmacol Biochem Behav; 1988 Oct; 31(2):255-63. PubMed ID: 2469085 [TBL] [Abstract][Full Text] [Related]
35. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. Devine DP; Leone P; Pocock D; Wise RA J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399 [TBL] [Abstract][Full Text] [Related]
36. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area. Elliott PJ; Alpert JE; Bannon MJ; Iversen SD Brain Res; 1986 Jan; 363(1):145-7. PubMed ID: 2418910 [TBL] [Abstract][Full Text] [Related]
37. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists. Juszczak M; Boczek-Leszczyk E J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097 [TBL] [Abstract][Full Text] [Related]
38. Pharmacological examination of the neurokinin-1 receptor mediating relaxation of human intralobar pulmonary artery. Pedersen KE; Buckner CK; Meeker SN; Undem BJ J Pharmacol Exp Ther; 2000 Jan; 292(1):319-25. PubMed ID: 10604965 [TBL] [Abstract][Full Text] [Related]
39. Capillary permeability induced by intravenous neurokinins. Receptor characterization and mechanism of action. Jacques L; Couture R; Drapeau G; Regoli D Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):170-9. PubMed ID: 2478892 [TBL] [Abstract][Full Text] [Related]
40. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists. Juszczak M Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]